Luca Bertamini
5PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 18, 2025
Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.Cathelijne Fokkema, Luca Bertamini, Madelon M E de Jong
|Oct 08, 2025
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone.Luca Bertamini, Cathelijne Fokkema, Paula Rodriguez-Otero
|Nov 21, 2024
Serum free light chains in a racially diverse population including African Americans and populations from South Africa.Luca Bertamini, Jean-Baptiste Alberge, David J Lee
|Oct 26, 2024
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study.Katarzyna Malgorzata Kwiatkowska, Nicola Martinelli, Luca Bertamini
|Jun 06, 2022
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.Luca Bertamini, Stefania Oliva, Delia Rota-Scalabrini
Pageof 1
Frequent Collaborators
2 joint publications
Pieter Sonneveld
2 joint publications
Vincent H J van der Velden
2 joint publications
Cathelijne Fokkema
1 joint publications
Mathijs Arnoud Sanders
1 joint publications
Delia Rota-Scalabrini
1 joint publications
Laura Paris
1 joint publications
Paolo Corradini
1 joint publications
Massimo Gentile
1 joint publications
Giovanni De Sabbata
1 joint publications
Patrizia Tosi
